PIGO
GPI ethanolamine phosphate transferase 3, catalytic subunit
Also known as: DKFZp434M222, FLJ00135, PIGO_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8TEQ8
- Gene
- PIGO
- Ensembl
- ENSG00000165282
- Chromosome
- 9
- Canonical length
- 1089 aa
- Protein class
- Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins
- Subcellular location
- Nucleoplasm,Nucleoli
OverviewNCBI Gene
This gene encodes a protein that is involved in glycosylphosphatidylinositol (GPI)-anchor biosynthesis. The GPI-anchor is a glycolipid which contains three mannose molecules in its core backbone. The GPI-anchor is found on many blood cells and serves to anchor proteins to the cell surface. This protein is involved in the transfer of ethanolaminephosphate (EtNP) to the third mannose in GPI. At least three alternatively spliced transcripts encoding two distinct isoforms have been found for this gene. [provided by RefSeq, Jan 2011]
Canonical amino-acid sequenceUniProt
1089 residues, UniProt reviewed canonical sequence.
>Q8TEQ8|PIGO
1 MQKASVLLFL AWVCFLFYAG IALFTSGFLL TRLELTNHSS CQEPPGPGSL PWGSQGKPGA
61 CWMASRFSRV VLVLIDALRF DFAQPQHSHV PREPPVSLPF LGKLSSLQRI LEIQPHHARL
121 YRSQVDPPTT TMQRLKALTT GSLPTFIDAG SNFASHAIVE DNLIKQLTSA GRRVVFMGDD
181 TWKDLFPGAF SKAFFFPSFN VRDLDTVDNG ILEHLYPTMD SGEWDVLIAH FLGVDHCGHK
241 HGPHHPEMAK KLSQMDQVIQ GLVERLENDT LLVVAGDHGM TTNGDHGGDS ELEVSAALFL
301 YSPTAVFPST PPEEPEVIPQ VSLVPTLALL LGLPIPFGNI GEVMAELFSG GEDSQPHSSA
361 LAQASALHLN AQQVSRFLHT YSAATQDLQA KELHQLQNLF SKASADYQWL LQSPKGAEAT
421 LPTVIAELQQ FLRGARAMCI ESWARFSLVR MAGGTALLAA SCFICLLASQ WAISPGFPFC
481 PLLLTPVAWG LVGAIAYAGL LGTIELKLDL VLLGAVAAVS SFLPFLWKAW AGWGSKRPLA
541 TLFPIPGPVL LLLLFRLAVF FSDSFVVAEA RATPFLLGSF ILLLVVQLHW EGQLLPPKLL
601 TMPRLGTSAT TNPPRHNGAY ALRLGIGLLL CTRLAGLFHR CPEETPVCHS SPWLSPLASM
661 VGGRAKNLWY GACVAALVAL LAAVRLWLRR YGNLKSPEPP MLFVRWGLPL MALGTAAYWA
721 LASGADEAPP RLRVLVSGAS MVLPRAVAGL AASGLALLLW KPVTVLVKAG AGAPRTRTVL
781 TPFSGPPTSQ ADLDYVVPQI YRHMQEEFRG RLERTKSQGP LTVAAYQLGS VYSAAMVTAL
841 TLLAFPLLLL HAERISLVFL LLFLQSFLLL HLLAAGIPVT TPGPFTVPWQ AVSAWALMAT
901 QTFYSTGHQP VFPAIHWHAA FVGFPEGHGS CTWLPALLVG ANTFASHLLF AVGCPLLLLW
961 PFLCESQGLR KRQQPPGNEA DARVRPEEEE EPLMEMRLRD APQHFYAALL QLGLKYLFIL
1021 GIQILACALA ASILRRHLMV WKVFAPKFIF EAVGFIVSSV GLLLGIALVM RVDGAVSSWF
1081 RQLFLAQQRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PIGO can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 14
- Mean surface accessibility (rSASA)
- 0.26
- Highest tissue expression
- 19 nTPM
Expression across tissuesHPA
Tissue
- parathyroid gland: 19 nTPM
- thyroid gland: 14 nTPM
- pancreas: 14 nTPM
- kidney: 13 nTPM
- salivary gland: 12 nTPM
- adrenal gland: 12 nTPM
Single-cell type
- syncytiotrophoblasts: 29 nCPM
- cytotrophoblasts: 27 nCPM
- early primary spermatocytes: 27 nCPM
- respiratory ionocytes: 23 nCPM
- fallopian tube ciliated cells: 22 nCPM
- extravillous trophoblasts: 21 nCPM
Immune cell
- myeloid DC: 9.6 nTPM
- plasmacytoid DC: 6.4 nTPM
- eosinophil: 5.7 nTPM
- intermediate monocyte: 5.6 nTPM
- basophil: 5.3 nTPM
- memory CD8 T-cell: 5.3 nTPM
Brain region
- white matter: 11 nTPM
- choroid plexus: 8.9 nTPM
- cerebellum: 7.7 nTPM
- medulla oblongata: 7.7 nTPM
- spinal cord: 7.4 nTPM
- basal ganglia: 6.9 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PIGO.
Disease | AllUniProt
Conditions PIGO is implicated in, by any mechanism.
- Hyperphosphatasia with impaired intellectual development syndrome 2 (HPMRS2) MIM:614749
Disease | GeneticClinVar
81 pathogenic / likely-pathogenic of 1,071 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Hyperphosphatasia with intellectual disability syndrome 2
- Hyperphosphatasia-intellectual disability syndrome
- Inborn genetic diseases
- Hyperphosphatasia with intellectual disability syndrome 1
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.81
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.96
- DepMap mean gene effect
- -0.1
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Type I phosphodiesterase/nucleotide pyrophosphatase/phosphate transferase
- Alkaline-phosphatase-like, core domain superfamily
- Type I phosphodiesterase / nucleotide pyrophosphatase
- GPI ethanolamine phosphate transferase 3, N-terminal
- GPI ethanolamine phosphate transferase 3
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PIGO as an antibody target. Whether an autoantibody or antibody against PIGO could matter depends on whether native PIGO is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PIGO is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PIGO as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...